James Levine - 15 Mar 2023 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Financial Officer
Signature
/s/ James Levine
Issuer symbol
CRDF
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
4
Filing time
16 Mar 2023, 17:42:11 UTC
Previous filing
19 Sep 2022
Next filing
07 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +197,472 +35% $0.000000 757,488 15 Mar 2023 Common Stock 197,472 $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on March 15, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.